PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16849547-10	2006	Lithium chloride (LiCl), an inhibitor of glycogen synthase kinase-3beta, increased cytosolic and nuclear beta-catenin level, NOS2 expression, and NO.	Lithium Chloride	0-16	nitric oxide synthase 2	Homo sapiens	125-129	
16849547-10	2006	Lithium chloride (LiCl), an inhibitor of glycogen synthase kinase-3beta, increased cytosolic and nuclear beta-catenin level, NOS2 expression, and NO.	Lithium Chloride	18-22	nitric oxide synthase 2	Homo sapiens	125-129	
16849547-13	2006	When administered in vivo, LiCl increased hepatic beta-catenin level in a dose-dependent manner with simultaneous increase in NOS2 expression.	Lithium Chloride	27-31	nitric oxide synthase 2	Homo sapiens	126-130	
29049420-8	2017	Furthermore, DAPT and LiCl decreased production of IL-1beta, TNF-alpha, IL-6, iNOS, Cox2 and MCP-1; however, IL-10 expression was increased notably in LiCl treated cells.	Lithium Chloride	22-26	nitric oxide synthase 2	Homo sapiens	78-82